Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 74 (2024): Issue 2 (June 2024)
Open Access
The potential of three-dimensional printing for pediatric oral solid dosage forms
Klemen Kreft
Klemen Kreft
,
Marina Fanous
Marina Fanous
and
Volker Möckel
Volker Möckel
| May 30, 2024
Acta Pharmaceutica
Volume 74 (2024): Issue 2 (June 2024)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
May 30, 2024
Page range:
229 - 248
Accepted:
Jan 04, 2024
DOI:
https://doi.org/10.2478/acph-2024-0012
Keywords
3D printing
,
personalized dosage forms
,
pediatric medication
,
compounded medicine
,
additive manufacturing
,
decentralized manufacturing
© 2024 Klemen Kreft et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Klemen Kreft
Lek Pharmaceuticals d.d., a Sandoz Company
Ljubljana, Slovenia
Marina Fanous
Novartis Pharma AG
Basel, Switzerland
Volker Möckel
Novartis Pharma AG
Basel, Switzerland